Palatin Tech announces notification of patent allowance for '238 application Palatin Technologies announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. Patent Application Serial Number 12/952,238. The application includes composition of matter claims on a new class of melanocortin receptor- specific peptides for sexual dysfunction and other indications. The '238 application is the first patent application to issue covering a novel family of melanocortin-4 receptor agonist peptides.
Palatin Tech requests withdrawal of registration statement The company has determined, due to market conditions, not to proceed at this time with the registration and sale of common stock as contemplated by the Registration Statement, File No. 333-198992.